"10.1371_journal.pone.0008825","plos one","2010-01-21T00:00:00Z","Myriam Rai; Elisabetta Soragni; C James Chou; Glenn Barnes; Steve Jones; James R Rusche; Joel M Gottesfeld; Massimo Pandolfo","Laboratoire de Neurologie Expérimentale, Hôpital Erasme, Brussels, Belgium; Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, United States of America; Repligen Corporation, Waltham, Massachusetts, United States of America","Conceived and designed the experiments: MR JRR JMG MP. Performed the experiments: MR ES CJC. Analyzed the data: MR ES CJC GB SJ JRR JMG MP. Contributed reagents/materials/analysis tools: GB SJ. Wrote the paper: MR ES CJC JRR JMG MP.","Repligen Corporation has acquired a license from the Scripps Research Institute for the development of the pimelic diphenylamide HDAC inhibitors first synthesized in the lab of JMG. Repligen filed for patenting the molecules described in this manuscript. GB, SJ and JRR are employees of Repligen and JMG is a consultant for Repligen. This corporate involvement does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2010","01","Myriam Rai","MR",8,TRUE,4,3,8,6,TRUE,TRUE,FALSE,0,NA,FALSE
